Literature DB >> 23539481

Diagnosis and misdiagnosis of cerebrovascular disease.

Vasileios-Arsenios Lioutas1, Shruti Sonni, Louis R Caplan.   

Abstract

OPINION STATEMENT: Stroke is the leading cause of disability and the third leading cause of death in the USA. Ischemic and hemorrhagic strokes must be distinguished since treatment is quite different. Ischemic strokes account for 80 % of the total and recent advances in management of brain ischemia have added valuable options to the physicians' armamentarium. Wise selection and targeted treatment of patients is of paramount importance. Properly treated patients benefit significantly, while those erroneously diagnosed as ischemic stroke are exposed to potentially harmful side effects of therapy. Stroke can present in the form of several different clinical syndromes some of which are difficult to identify. Conversely, there are numerous conditions whose clinical presentation closely resembles stroke, also known as stroke mimics. Ancillary testing, especially imaging, is a crucial part of diagnostic evaluation, while clinical judgment, thorough knowledge of cerebrovascular anatomy and familiarity with characteristic stroke syndromes remain indispensable even in this era of technological advance.

Entities:  

Year:  2013        PMID: 23539481     DOI: 10.1007/s11936-013-0233-x

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  53 in total

1.  Paroxysmal attacks in multiple sclerosis.

Authors:  P O Ostermann; C E Westerberg
Journal:  Brain       Date:  1975-06       Impact factor: 13.501

2.  Visual symptoms in the migraine syndrome.

Authors:  V C Hachinski; J Porchawka; J C Steele
Journal:  Neurology       Date:  1973-06       Impact factor: 9.910

3.  Paroxysmal symptoms as the first manifestations of multiple sclerosis.

Authors:  J A Twomey; M L Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

4.  Normal diffusion-weighted MRI during stroke-like deficits.

Authors:  H Ay; F S Buonanno; G Rordorf; P W Schaefer; L H Schwamm; O Wu; R G Gonzalez; K Yamada; G A Sorensen; W J Koroshetz
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

5.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

6.  Exclusion criteria for intravenous thrombolysis in stroke mimics: an observational study.

Authors:  Alejandro M Brunser; Sergio Illanes; Pablo M Lavados; Paula Muñoz; Daniel Cárcamo; Arnold Hoppe; Verónica V Olavarria; Iris Delgado; Violeta Díaz
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-14       Impact factor: 2.136

7.  The incidence of stroke mimics among stroke department admissions in relation to age group.

Authors:  Patrick C A J Vroomen; Marieke K Buddingh; Gert Jan Luijckx; Jacques De Keyser
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Nov-Dec       Impact factor: 2.136

8.  The transience and nature of cognitive impairments in transient global amnesia: a meta-analysis.

Authors:  Theodor Jäger; Hansjörg Bäzner; Matthias Kliegel; Kristina Szabo; Michael G Hennerici
Journal:  J Clin Exp Neuropsychol       Date:  2009-01       Impact factor: 2.475

9.  Cerebellar infarction: comparison of computed tomography and magnetic resonance imaging.

Authors:  Z Simmons; J Biller; H P Adams; V Dunn; C G Jacoby
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

10.  Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome.

Authors:  David T Winkler; Felix Fluri; Peter Fuhr; Stephan G Wetzel; Philippe A Lyrer; Stephan Ruegg; Stefan T Engelter
Journal:  Stroke       Date:  2009-01-22       Impact factor: 7.914

View more
  1 in total

1.  Stroke mimic diagnoses presenting to a hyperacute stroke unit.

Authors:  Ang Dawson; Geoffrey C Cloud; Anthony C Pereira; Barry J Moynihan
Journal:  Clin Med (Lond)       Date:  2016-10       Impact factor: 2.659

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.